By Richard Sima The Washington Post Five years since the pandemic began, millions of people are still grappling with long COVID, even as new patients are joining their ranks. “Considering […]
Long COVID 2025: Symptoms, diagnosis, post-COVID treatments and the latest long COVID research
Welcome to the AMA Update video and podcast. Today, we’re talking about the latest on long COVID with Dr. Akiko Iwasaki, the Sterling Professor of Immunobiology at Yale University in […]
COVID-19 coagulopathy, thrombosis, and bleeding
Noel C. Chan, Jeffrey I. Weitz, Blood (2020) 136 (4): 381–383.https://doi.org/10.1182/blood.2020007335 In this issue of Blood, Al-Samkari et al expand our understanding of thrombosis and bleeding risks and their predictors in hospitalized patients with […]
Hidden heart and lung damage detected in patients with long COVID
Mount Sinai Health System Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection-even when standard medical tests […]
🦠 Long COVID and Urinary Tract Infections (UTIs): 2025 Insights into Etiology, Symptoms, Progression, and Renal Complications
Emerging 2025 research reveals a compelling link between Long COVID and urinary tract infections (UTIs), with implications for kidney damage, bladder dysfunction, and chronic urinary symptoms. This article synthesizes findings […]
Research at St. Paul’s Hospital uncovers cause of lung long COVID
New research from the Centre for Heart Lung Innovation (HLI) at St. Paul’s Hospital has identified inflammation in the lungs’ smallest airways as the cause of pulmonary long COVID. A […]
Peripheral Immune-Mediated Neuropathy Before and During the COVID-19 Pandemic: A Retrospective Cross-Sectional Study in a Referral Center
Abstract Background: There are currently seven coronaviruses that can infect humans and the latest addition to these viruses is the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Infection by SARS-CoV-2 is […]
Long COVID: The Latest on Treatment and Recovery
For many people, a case of COVID-19 lasts a week or two. For millions of adults, though, symptoms stick around for weeks, months, even years. Long COVID is associated with […]
Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID
Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736 Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor […]
Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy
Baneet Kaur • Cyril Blavo • Mayur S. Parmar, DOI: 10.7759/cureus.56025 Abstract Ivermectin was first discovered in the 1970s by Japanese microbiologist Satoshi Omura and Irish parasitologist William C. Campbell. Ivermectin has become a versatile […]